MedKoo Cat#: 571535 | Name: Cyprodenate
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cyprodenate is a stimulant drug that was previously investigated for its potential to counteract barbiturate-induced sedation and coma. Its bioactivity primarily involves increasing neuronal excitability, likely through modulation of neurotransmitter systems, although its precise mechanism remains unclear. Cyprodenate has been shown to enhance locomotor activity and cognitive function in animal models, suggesting potential nootropic effects.

Chemical Structure

Cyprodenate
Cyprodenate
CAS#15585-86-1 (free base)

Theoretical Analysis

MedKoo Cat#: 571535

Name: Cyprodenate

CAS#: 15585-86-1 (free base)

Chemical Formula: C13H25NO2

Exact Mass: 227.1885

Molecular Weight: 227.35

Elemental Analysis: C, 68.68; H, 11.08; N, 6.16; O, 14.07

Price and Availability

Size Price Availability Quantity
25mg USD 350.00 2 Weeks
50mg USD 550.00 2 Weeks
100mg USD 950.00 2 Weeks
1g USD 3,450.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Cyprodenate; Actebral
IUPAC/Chemical Name
2-(Dimethylamino)ethyl cyclohexanepropionate
InChi Key
MPOYJPINNSIHAK-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H25NO2/c1-14(2)10-11-16-13(15)9-8-12-6-4-3-5-7-12/h12H,3-11H2,1-2H3
SMILES Code
O=C(OCCN(C)C)CCC1CCCCC1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Solvent mg/mL mM
Solubility
Soluble in DMSO 0.0 100.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 227.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Dormard Y, Levron JC, Benakis A. Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals. Arzneimittelforschung. 1975 Feb;25(2):194-201. PubMed PMID: 1173032. 2: Dormard Y, Levron JC, Le Fur JM. Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals. Arzneimittelforschung. 1975 Feb;25(2):201-7. PubMed PMID: 1173033. 3: Bobkov IuG, Morozov IS. [Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychostimulants]. Biull Eksp Biol Med. 1982 Oct;94(10):48-51. Russian. PubMed PMID: 6129008. 4: Förster A, Falcone FH, Gibbs BF, Preussner LM, Fiebig BS, Altunok H, Seeger JM, Cerny-Reiterer S, Rabenhorst A, Papenfuss K, Valent P, Kashkar H, Hartmann K. Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils. Leuk Lymphoma. 2013 Apr;54(4):835-42. doi: 10.3109/10428194.2012.731600. Epub 2012 Oct 9. PubMed PMID: 22989017. 5: Bergener M, Freistein H. The use of Wittenborn psychiatric rating scales in geriatric psychiatry. Results of a double blind study with cyprodenate and placebo. Arzneimittelforschung. 1972 Dec;22(12):2058-63. German. PubMed PMID: 4575344.